Cannalink, Inc. (CNLK) operates as a development-stage company focused on the cannabis industry, primarily providing web development and graphic design services tailored to cannabis-related businesses; it also intends to develop cannabidiol (CBD)-based products, including sublingual formulations like those derived from the acquired MigraSpray technology for migraine treatment and potential healthcare distribution. The company offers specialized website design for marijuana enterprises and business consulting, merchant banking, and investment services targeting emerging medical marijuana and industrial hemp companies. Its services emphasize digital solutions for the cannabis sector, with historical involvement in joint ventures such as Hempwire, LLC.
Founded on August 29, 1997, and headquartered at 110 West C Street, Suite 1300, San Diego, California 92101, United States, Cannalink previously operated under the name Superwire, Inc. prior to a significant name change and 1-for-50 reverse stock split in September 2014, alongside the $300,000 acquisition of the MigraSpray product line and assets to support CBD product development. The company maintains a presence on OTC Pink Sheets (OTCPK) since June 1998 and targets healthcare practitioners, cannabis operators, and emerging firms in the pharmaceuticals, biotech, and specialty telecommunications segments. No recent partnerships, funding rounds, acquisitions, or product launches within the last 1-2 years are publicly reported, reflecting its current development-stage status with limited operational disclosures.